Target Name: WDR72
NCBI ID: G256764
Review Report on WDR72 Target / Biomarker Content of Review Report on WDR72 Target / Biomarker
WDR72
Other Name(s): OTTHUMP00000162771 | WD repeat domain 72 | WD repeat-containing protein 72 (isoform a) | FLJ38736 | MGC126663 | AI2A3 | MGC126665 | WDR72 variant 1 | WD repeat-containing protein 72 | WDR72_HUMAN | WD repeat domain 72, transcript variant 1

WDR72: A Potential Drug Target and Biomarker

Welcome to this article on WDR72, a gene that has garnered significant interest due to its potential as a drug target and biomarker. WDR72 is a non-coding RNA molecule that has been identified using RNA sequencing techniques. The gene has not been previously associated with any disease, but recent studies have hinted at its potential role in several diseases, including cancer.

The WDR72 gene is located on chromosome 6p21.2 and has a length of 1,384 nucleotides. It is expressed in nearly all tissue types, including muscle, skin, and brain. The gene has been shown to be involved in several cellular processes, including cell adhesion, migration, and transcriptional regulation.

The most promising aspect of WDR72 is its potential as a drug target. WDR72 has been shown to play a role in several diseases, including cancer. Studies have shown that high levels of WDR72 expression are associated with poor prognosis in cancer patients. Additionally, WDR72 has been shown to promote the growth and survival of cancer cells, which could make it an attractive target for cancer treatments.

WDR72 has also been shown to be involved in several signaling pathways, including the TGF-β pathway. This pathway is involved in cell growth, differentiation, and survival, and has been implicated in several diseases, including cancer. The TGF-β pathway is a potential target for cancer treatments, and WDR72 has been shown to contribute to its activity.

In addition to its potential as a drug target, WDR72 has also been shown to be a potential biomarker. The expression of WDR72 has been shown to be associated with several diseases, including cancer. This suggests that WDR72 may be a useful biomarker for monitoring disease progression and responding to therapeutic interventions.

WDR72 has also been shown to be involved in several cellular processes that are important for normal cellular function. The gene has been shown to be involved in cell adhesion, which is the process by which cells stick together to form tissues and organs. It has also has been shown to be involved in the regulation of cell migration, which is the process by which cells move from one location to another in the body.

In conclusion, WDR72 is a gene that has shown promising potential as a drug target and biomarker. Its involvement in several cellular processes makes it an attractive target for therapeutic interventions, and its potential as a drug target and biomarker makes it an important area of 鈥嬧?媟esearch . Further studies are needed to fully understand the role of WDR72 in diseases and to develop effective treatments based on its potential.

Protein Name: WD Repeat Domain 72

Functions: Plays a major role in formation of tooth enamel (PubMed:19853237, PubMed:25008349). Specifically required during the maturation phase of amelogenesis for normal formation of the enamel matrix and clearance of enamel proteins. May be involved in localization of the calcium transporter SLC24A4 to the ameloblast cell membrane

The "WDR72 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR72 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1